Hyperfine, Inc. SEC filings HYPR

Hyperfine, Inc. has 367 filings in SEC EDGAR's recent list, going back to Dec 9, 2020. Its latest annual report, Form ARS, was filed on Apr 8, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 8, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.

Hyperfine, Inc. SEC filings
Form Description Filed Period
DEFA14A Additional proxy material Apr 8, 2026 —
DEF 14A Proxy statement Apr 8, 2026 May 21, 2026
DEFA14A Additional proxy material Apr 7, 2025 —
DEF 14A Proxy statement Apr 7, 2025 May 19, 2025
DEFA14A Additional proxy material Apr 26, 2024 —
DEF 14A Proxy statement Apr 26, 2024 Jun 11, 2024
PRE 14A Preliminary proxy statement Apr 16, 2024 Jun 11, 2024
DEFA14A Additional proxy material Apr 24, 2023 —
DEF 14A Proxy statement Apr 24, 2023 Jun 8, 2023
PRE 14A Preliminary proxy statement Apr 13, 2023 Jun 8, 2023
DEF 14C Information statement Oct 6, 2022 Oct 6, 2022
PRE 14C Filing Sep 26, 2022 Sep 26, 2022
DEFA14A Additional proxy material Apr 25, 2022 —
DEF 14A Proxy statement Apr 25, 2022 Jun 8, 2022

Showing 14 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Listed as
HYPR (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Guilford, CT
SEC filer status
, Emerging growth company
SEC CIK
1833769
Former names
HealthCor Catalio Acquisition Corp. (until Dec 22, 2021)

Other Electromedical & Electrotherapeutic Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.